Finance

Lists
LIA:FRA
LivaNova PLC
€70.50
+0.71%
(+0.50) 1D
Sep 7, 8:02:22 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for LIA...
Open
€70.50
High
€70.50
Low
€70.50
Mkt. cap
4.51B
Avg. vol.
11.00
Volume
0.00
52-wk high
€74.50
52-wk low
€42.80
No. of employees
3K
Open
€70.50
High
€70.50
Low
€70.50
Mkt. cap
4.51B
Avg. vol.
11.00
Volume
0.00
52-wk high
€74.50
52-wk low
€42.80
No. of employees
3K
Profile
LivaNova, plc is a medical device manufacturer that is a foreign domiciled company based in the U.K. for tax inversion purposes. With operational headquarters in the United States. The company develops devices used for cardiac surgery and neuromodulation. The company was formed in 2015 by a $2.7B merger between Houston, Texas-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a. The company trades on the NASDAQ stock exchange under the ticker symbol "LIVN". Wikipedia
About LivaNova PLC
CEOVladimir Makatsaria
Employees3.3K
Founded1987
Headquarters-
SectorMedical device
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
357.75M
360.92M
362.26M
390.59M
Cost of goods sold
111.70M
120.05M
117.41M
125.62M
Cost of revenue
111.70M
120.05M
117.41M
125.62M
Research and development expenses
48.58M
48.52M
49.14M
52.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
138.42M
143.66M
143.57M
158.13M
Operating expense
187.00M
194.07M
192.71M
212.07M
Total operating expenses
298.70M
314.12M
310.12M
337.68M
Operating income
59.06M
46.81M
52.14M
52.90M
Other non operating income
-11.21M
378.36M
-7.53M
-38.73M
EBT including unusual items
33.90M
27.62M
26.63M
18.36M
EBT excluding unusual items
40.05M
393.28M
38.44M
8.14M
Income tax expense
7.11M
-3.28M
4.34M
-90.20M
Effective tax rate
20.99%
-11.88%
16.29%
-491.17%
Other operating expenses
-
1.88M
-
1.08M
Net income
26.78M
30.91M
22.29M
108.57M
Net profit margin
7.49%
8.56%
6.15%
27.80%
Earnings per share
1.11
0.86
0.98
1.26
Interest and investment income
3.90M
4.46M
3.55M
3.83M
Interest expense
-10.86M
-10.86M
-8.29M
-7.18M
Net interest expenses
-6.96M
-6.40M
-4.74M
-3.34M
Depreciation and amortization charges
-
-
-
-
EBITDA
71.30M
58.88M
65.00M
68.32M
Gain or loss from assets sale
-
-4.13M
-
-
AI content may include mistakes. Learn more
Google apps